Literature DB >> 8450856

Treatment of non-Hodgkin's lymphoma.

J O Armitage1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8450856     DOI： 10.1056/NEJM199304083281409

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

1.  Drug discovery: engineering drug combinations.

Authors:  Scott J Dixon; Brent R Stockwell
Journal:  Nat Chem Biol       Date:  2010-05       Impact factor: 15.040

2.  A Historical Tale of Two Lymphomas: Part II: Non-Hodgkin lymphoma.

Authors:  Ritu Lakhtakia; Ikram Burney
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24

3.  A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002.

Authors:  Tomohiro Kinoshita; Tomomitsu Hotta; Kensei Tobinai; Tohru Kobayashi; Naoki Ishizuka; Masao Tomonaga; Toshiaki Sai; Youichiro Ohno; Masaharu Kasai; Michinori Ogura; Chikara Mikuni; Hironobu Toki; Masayuki Sano; Yasufumi Masaki; Tomoko Ohtsu; Yoshihiro Matsuno; Takeaki Takenaka; Shigeru Shirakawa; Masanori Shimoyama
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

Review 4.  Hyperglycemia in patients with hematologic malignancies.

Authors:  Sara J Healy; Kathleen M Dungan
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

Review 5.  Cost-effective use of autologous bone marrow transplantation: few answers, many questions, and suggestions for future assessments.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

Review 6.  Gene arrays in lymphoma: Where will they fit in?

Authors:  Javeed Iqbal; Francesco d'Amore; Qinglong Hu; Wing C Chan; Kai Fu
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

Review 7.  New insights into tumor-host interactions in lymphoma metastasis.

Authors:  V Umansky; V Schirrmacher; M Rocha
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

Review 8.  Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

Authors:  Ruth Whittington; Diana Faulds
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

9.  High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

Authors:  C Hosing; R M Saliba; G-J Okoroji; U Popat; D Couriel; T Ali; L De Padua Silva; P Kebriaei; A Alousi; M De Lima; M Qazilbash; P Anderlini; S Giralt; R E Champlin; I Khouri
Journal:  Ann Oncol       Date:  2008-02-13       Impact factor: 32.976

Review 10.  Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.